Skip to main content
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: Am Heart J. 2020 Jan 21;222:38–45. doi: 10.1016/j.ahj.2020.01.008

Figure I.

Figure I.

Sample selection for eligible privately-insured women aged 15–44 years with and without congenital heart defects (CHD), and CHD severity

*Women who were aged 15–44 years in 2014, had prescription drug coverage included in the database in 2014, and were enrolled for ≥11 months per year annually during 2011–2014. Pregnancy was defined using end of pregnancy billing codes using an algorithm published previously.9